Results 21 to 30 of about 664,130 (306)

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. [PDF]

Am J Trop Med Hyg, 2021
. Oral cholera vaccination protects against cholera; however, responses in young children are low and of short duration. The best current correlates of protection against cholera target Vibrio cholerae O-specific polysaccharide (anti-OSP), including ...
Akter A, Kelly M, Charles RC, Harris JB, Calderwood SB, Bhuiyan TR, Biswas R, Xu P, Kováč P, Qadri F, Ryan ET.   +10 more
europepmc   +2 more sources

Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine

Infection and Immunity, 2021
Cholera is a diarrheal disease caused by Vibrio cholerae that continues to be a major public health concern in populations without access to safe water. IgG- and IgA-secreting memory B cells (MBC) targeting the V. cholerae O-specific polysaccharide (OSP)
Denise Chac, T. Bhuiyan, A. Saha, M. M. Alam, U. Salma, N. Jahan, F. Chowdhury, A. Khan, E. Ryan, R. Larocque, J. Harris, F. Qadri, Ana A. Weil   +12 more
semanticscholar   +1 more source

Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers [PDF]

Vaccines, 2020
Cholera is endemic in approximately 50 countries, primarily in Africa and South and Southeast Asia, and in these areas, it remains a disease associated with poverty. In developed nations, cholera is rare, and cases are typically imported from endemic areas by returning travellers.
Giovanni Gabutti, Andrea Rossanese, Alberto Tomasi, Sandro Giuffrida, Vincenzo Nicosia, Juan Barriga, Caterina Florescu, Federica Sandri, Armando Stefanati   +8 more
openaire   +4 more sources

Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. [PDF]

PLoS ONE, 2014
There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera.
Jacqueline Deen, Mohammad Ali, David Sack   +2 more
doaj   +1 more source

Controlling cholera in the Ouest Department of Haiti using oral vaccines. [PDF]

PLoS Neglected Tropical Diseases, 2017
Following the 2010 cholera outbreak in Haiti, a plan was initiated to provide massive improvements to the sanitation and drinking water infrastructure in order to eliminate cholera from the island of Hispaniola by 2023.
Alexander Kirpich, Thomas A Weppelmann, Yang Yang, John Glenn Morris, Ira M Longini   +4 more
doaj   +1 more source

IMPROVEMENT OF SPECIFIC CHOLERA PREVENTION USING IMMUNOMODULATORS

Медицинская иммунология, 2021
It is known that the combined use of vaccines, cytokines and various immunomodulatory drugs contributes to the development of a full-fledged immune response.
A. V. Filippenko, N. D. Omelchenko, N. I. Pasyukova, A. A. Trufanova, I. A. Ivanova   +4 more
doaj   +1 more source

Vaccination against cholera in Juba [PDF]

The Lancet Infectious Diseases, 2017
In an interesting Personal View, Lucy Parker and colleagues1 reported the difficulties regarding implementation of a reactive oral cholera vaccination (OCV) campaign during the 2015 cholera epidemic in Juba, South Sudan.1 They support the choice to address the global shortage of vaccines by providing just one dose to twice the number of people. However,
Rebaudet, Stanislas, Gaudart, Jean, Piarroux, Renaud   +2 more
openaire   +4 more sources

Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda

BMJ Open, 2020
Objectives To evaluate the quality and coverage of the campaign to distribute oral cholera vaccine (OCV) during a cholera outbreak in Hoima, Uganda to guide future campaigns of cholera vaccine.
Godfrey Bwire, Mellisa Roskosky, A. Ballard, W. A. Brooks, Alfred Okello, F. Rafael, I. Ampeire, C. G. Orach, D. Sack   +8 more
semanticscholar   +1 more source

Oral vaccines for preventing cholera [PDF]

Cochrane Database of Systematic Reviews, 2010
This review is superseded by the published Cochrane Review, Saif‐Ur‐Rahman 2024 [https://doi.org/10.1002/14651858.CD014573], which considers only the oral killed vaccines because the live oral vaccines do not have World Health Organization (WHO) prequalification. Saif‐Ur‐Rahman 2024 also considered only currently available WHO pre‐qualified oral killed
Sinclair, David, Abba, Katharine, Zaman, K., Qadri, Firdausi, Graves, Patricia M.   +4 more
openaire   +4 more sources

Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. [PDF]

, 2012
In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its use in Sub-Saharan Africa has been limited ...
Ali Djibo, Augusto E Llosa, Bachir Mayana, D Sinclair, D Sur, DA Sack, Global Task Force on Cholera Control, Guidelines Working Group, IM Longini, J Guerra, JD Clemens, JL Deen, Jose Guerra, M Ali, M Enserink, M Jeuland, Mahamane L Manzo, Meeting of the Strategic advisory Group of Experts on immunization, R development Core Team, Rebecca F Grais, RI Glass, République du Niger, World Health Organization Regional Office for Africa and the Centers for Disease Control and Prevention   +22 more
core   +3 more sources